Tilray Brands (TLRY) Net Margin (QoQ) (2017 - 2026)
Tilray Brands (TLRY) Net Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.20 Bn | 43.24 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.43 Bn | 39.78 Bn | 2.15 Bn |
| 3 | Zoetis | 32.03 Bn | 30.35 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.42 Bn | 19.76 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.05 Bn | 11.52 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.92 Bn | - |
| 10 | Tilray Brands | 539.03 Mn | 304.40 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 169.00 |
| Feb 28, 2026 | 780.00 |
| Nov 30, 2025 | -2,073.00 |
| Aug 31, 2025 | 40,387.00 |
| May 31, 2025 | 2,399.00 |
| Feb 28, 2025 | -38,671.00 |
| Nov 30, 2024 | -2,310.00 |
| Aug 31, 2024 | -2,138.00 |
| May 31, 2024 | 5,980.00 |
| Feb 29, 2024 | -3,191.00 |
| Nov 30, 2023 | 774.00 |
| Aug 31, 2023 | -12,796.00 |
| May 31, 2023 | 91,771.00 |
| Feb 28, 2023 | -76,231.00 |
| Nov 30, 2022 | -1,607.00 |
| Aug 31, 2022 | 19,955.00 |
| May 31, 2022 | -27,704.00 |
| Feb 28, 2022 | 3,082.00 |
| Nov 30, 2021 | 2,433.00 |
| Aug 31, 2021 | -20,965.00 |